RK

Ravi Kumar Murali Krishnan

Active Director Director DIN 09698422
DIN 09698422 First appointment Aug 2025 Primary industry Healthcare
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Aug 2025
Shareholding value β€’β€’β€’β€’ Premium profile

About Ravi Kumar Murali Krishnan

Data last updated:

Ravi Kumar Murali Krishnan is a Director at Wyga Ayurveda Private Limited (since 2025). The company operates in Healthcare.

DIN 09698422
Primary Designation Director
Industry Healthcare
First Appointment 27 Aug 2025
Oldest Company Age 1 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Wyga Ayurveda Private Limited U86901KL2025PTC096681
Director27 Aug 20252025Active

Board colleagues of Ravi Kumar Murali Krishnan

NameDINCompanyDesignation
Krishnamurthy Hemamalini11264327Wyga Ayurveda Private LimitedDirector

Directorship timeline

Open interactive timeline →
Wyga Ayurveda Private Limited
Premium access

Shareholding and investment profile for Ravi Kumar Murali Krishnan

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Ravi Kumar Murali Krishnan

Ravi Kumar Murali Krishnan currently holds 1 directorship: Wyga Ayurveda Private Limited (Director, since 27 Aug 2025).

Ravi Kumar Murali Krishnan was first appointed on 27 Aug 2025 as Director at Wyga Ayurveda Private Limited.

The current boards of Ravi Kumar Murali Krishnan's companies include Krishnamurthy Hemamalini (Wyga Ayurveda Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available